share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144:擬議出售證券
美股SEC公告 ·  05/20 15:36

Moomoo AI 已提取核心訊息

Vertex Pharmaceuticals Inc. officer and director, Kewalramani Reshma, is set to sell 15,202 shares of common stock on 05/20/2024, with an aggregate market value of approximately $6,795,294. The shares to be sold were acquired through restricted stock vesting as part of compensation from the issuer on various dates ranging from 02/10/2023 to 02/24/2024. The total number of shares acquired through these transactions was 15,202, matching the number of shares intended for sale. No securities sales have been reported in the past three months prior to the notice date of 05/20/2024.
Vertex Pharmaceuticals Inc. officer and director, Kewalramani Reshma, is set to sell 15,202 shares of common stock on 05/20/2024, with an aggregate market value of approximately $6,795,294. The shares to be sold were acquired through restricted stock vesting as part of compensation from the issuer on various dates ranging from 02/10/2023 to 02/24/2024. The total number of shares acquired through these transactions was 15,202, matching the number of shares intended for sale. No securities sales have been reported in the past three months prior to the notice date of 05/20/2024.
Vertex Pharmicals Inc.高管兼董事Kewalramani Reshma定於2024年5月20日出售15,202股普通股,總市值約爲6,795,294美元。待出售的股票是通過限制性股票歸屬收購的,作爲發行人補償的一部分,日期爲2023年10月2日至2024年2月24日。通過這些交易獲得的股票總數爲15,202股,與擬出售的股票數量相當。在2024年5月20日通知日期之前的過去三個月中,沒有報告任何證券銷售情況。
Vertex Pharmicals Inc.高管兼董事Kewalramani Reshma定於2024年5月20日出售15,202股普通股,總市值約爲6,795,294美元。待出售的股票是通過限制性股票歸屬收購的,作爲發行人補償的一部分,日期爲2023年10月2日至2024年2月24日。通過這些交易獲得的股票總數爲15,202股,與擬出售的股票數量相當。在2024年5月20日通知日期之前的過去三個月中,沒有報告任何證券銷售情況。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息